カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のロピバカイン注射液市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Ropivacaine Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM8036）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM8036
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のロピバカイン注射液市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のロピバカイン注射液の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のロピバカイン注射液市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ロピバカイン注射液の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ロピバカイン注射液市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・2 mg/mL (0.2%)、5 mg/mL (0.5%)、7.5 mg/mL (0.75%)、10 mg/mL (1%)

用途別セグメント
・外科麻酔、主要神経ブロック、急性疼痛管理、その他

主要な市場プレーヤー
・Pfizer、Akorn、Anant Pharmaceuticals、SGPharma、Nephron Pharmaceuticals、Sintetica SA、AstraZeneca、Manus Aktteva Biopharma LLP、Zhejiang Xianju Pharmaceutical Co.,Ltd、Jiangsu Nhwa Pharmaceutical Co.,Ltd.、Yangzi River Pharmaceutical Group、Jiangsu Hengrui Pharmaceuticals Co., Ltd.、Jiangsu Nhwa Pharmaceutical Co.,Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ロピバカイン注射液製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なロピバカイン注射液メーカーの企業概要、2019年～2022年までのロピバカイン注射液の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なロピバカイン注射液メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ロピバカイン注射液の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのロピバカイン注射液のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのロピバカイン注射液市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびロピバカイン注射液の産業チェーンを掲載しています。
・第14、15章では、ロピバカイン注射液の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ロピバカイン注射液の概要
– タイプ別分析（2018年vs2022年vs2029年）：2 mg/mL (0.2%)、5 mg/mL (0.5%)、7.5 mg/mL (0.75%)、10 mg/mL (1%)
– 用途別分析（2018年vs2022年vs2029年）：外科麻酔、主要神経ブロック、急性疼痛管理、その他
– 世界のロピバカイン注射液市場規模・予測
– 世界のロピバカイン注射液生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Akorn、Anant Pharmaceuticals、SGPharma、Nephron Pharmaceuticals、Sintetica SA、AstraZeneca、Manus Aktteva Biopharma LLP、Zhejiang Xianju Pharmaceutical Co.,Ltd、Jiangsu Nhwa Pharmaceutical Co.,Ltd.、Yangzi River Pharmaceutical Group、Jiangsu Hengrui Pharmaceuticals Co., Ltd.、Jiangsu Nhwa Pharmaceutical Co.,Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：2 mg/mL (0.2%)、5 mg/mL (0.5%)、7.5 mg/mL (0.75%)、10 mg/mL (1%)
・用途別分析2018年-2029年：外科麻酔、主要神経ブロック、急性疼痛管理、その他
・ロピバカイン注射液の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ロピバカイン注射液のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ロピバカイン注射液のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ロピバカイン注射液の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ロピバカイン注射液の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Ropivacaine Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Ropivacaine Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 2 mg/mL (0.2%)
1.3.3 5 mg/mL (0.5%)
1.3.4 7.5 mg/mL (0.75%)
1.3.5 10 mg/mL (1%)
1.4 Market Analysis by Application
1.4.1 Overview: Global Ropivacaine Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Surgical Anesthesia
1.4.3 Major Nerve Block
1.4.4 Acute Pain Management
1.4.5 Other
1.5 Global Ropivacaine Injection Market Size & Forecast
1.5.1 Global Ropivacaine Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Ropivacaine Injection Sales Quantity (2018-2029)
1.5.3 Global Ropivacaine Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Ropivacaine Injection Product and Services
2.1.4 Pfizer Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Ropivacaine Injection Product and Services
2.2.4 Akorn Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Akorn Recent Developments/Updates
2.3 Anant Pharmaceuticals
2.3.1 Anant Pharmaceuticals Details
2.3.2 Anant Pharmaceuticals Major Business
2.3.3 Anant Pharmaceuticals Ropivacaine Injection Product and Services
2.3.4 Anant Pharmaceuticals Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Anant Pharmaceuticals Recent Developments/Updates
2.4 SGPharma
2.4.1 SGPharma Details
2.4.2 SGPharma Major Business
2.4.3 SGPharma Ropivacaine Injection Product and Services
2.4.4 SGPharma Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SGPharma Recent Developments/Updates
2.5 Nephron Pharmaceuticals
2.5.1 Nephron Pharmaceuticals Details
2.5.2 Nephron Pharmaceuticals Major Business
2.5.3 Nephron Pharmaceuticals Ropivacaine Injection Product and Services
2.5.4 Nephron Pharmaceuticals Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nephron Pharmaceuticals Recent Developments/Updates
2.6 Sintetica SA
2.6.1 Sintetica SA Details
2.6.2 Sintetica SA Major Business
2.6.3 Sintetica SA Ropivacaine Injection Product and Services
2.6.4 Sintetica SA Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sintetica SA Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Ropivacaine Injection Product and Services
2.7.4 AstraZeneca Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 Manus Aktteva Biopharma LLP
2.8.1 Manus Aktteva Biopharma LLP Details
2.8.2 Manus Aktteva Biopharma LLP Major Business
2.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Product and Services
2.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
2.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
2.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
2.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
2.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
2.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
2.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
2.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Details
2.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
2.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product and Services
2.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.11 Yangzi River Pharmaceutical Group
2.11.1 Yangzi River Pharmaceutical Group Details
2.11.2 Yangzi River Pharmaceutical Group Major Business
2.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Product and Services
2.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
2.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
2.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
2.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
2.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product and Services
2.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
2.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
2.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Details
2.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
2.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
2.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates
3 Competitive Environment: Ropivacaine Injection by Manufacturer
3.1 Global Ropivacaine Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Ropivacaine Injection Revenue by Manufacturer (2018-2023)
3.3 Global Ropivacaine Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Ropivacaine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Ropivacaine Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Ropivacaine Injection Manufacturer Market Share in 2022
3.5 Ropivacaine Injection Market: Overall Company Footprint Analysis
3.5.1 Ropivacaine Injection Market: Region Footprint
3.5.2 Ropivacaine Injection Market: Company Product Type Footprint
3.5.3 Ropivacaine Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ropivacaine Injection Market Size by Region
4.1.1 Global Ropivacaine Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Ropivacaine Injection Consumption Value by Region (2018-2029)
4.1.3 Global Ropivacaine Injection Average Price by Region (2018-2029)
4.2 North America Ropivacaine Injection Consumption Value (2018-2029)
4.3 Europe Ropivacaine Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Ropivacaine Injection Consumption Value (2018-2029)
4.5 South America Ropivacaine Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Ropivacaine Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Ropivacaine Injection Sales Quantity by Type (2018-2029)
5.2 Global Ropivacaine Injection Consumption Value by Type (2018-2029)
5.3 Global Ropivacaine Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Ropivacaine Injection Sales Quantity by Application (2018-2029)
6.2 Global Ropivacaine Injection Consumption Value by Application (2018-2029)
6.3 Global Ropivacaine Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Ropivacaine Injection Sales Quantity by Type (2018-2029)
7.2 North America Ropivacaine Injection Sales Quantity by Application (2018-2029)
7.3 North America Ropivacaine Injection Market Size by Country
7.3.1 North America Ropivacaine Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Ropivacaine Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Ropivacaine Injection Sales Quantity by Type (2018-2029)
8.2 Europe Ropivacaine Injection Sales Quantity by Application (2018-2029)
8.3 Europe Ropivacaine Injection Market Size by Country
8.3.1 Europe Ropivacaine Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Ropivacaine Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Ropivacaine Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Ropivacaine Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Ropivacaine Injection Market Size by Region
9.3.1 Asia-Pacific Ropivacaine Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Ropivacaine Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Ropivacaine Injection Sales Quantity by Type (2018-2029)
10.2 South America Ropivacaine Injection Sales Quantity by Application (2018-2029)
10.3 South America Ropivacaine Injection Market Size by Country
10.3.1 South America Ropivacaine Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Ropivacaine Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Ropivacaine Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Ropivacaine Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Ropivacaine Injection Market Size by Country
11.3.1 Middle East & Africa Ropivacaine Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Ropivacaine Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Ropivacaine Injection Market Drivers
12.2 Ropivacaine Injection Market Restraints
12.3 Ropivacaine Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Ropivacaine Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ropivacaine Injection
13.3 Ropivacaine Injection Production Process
13.4 Ropivacaine Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ropivacaine Injection Typical Distributors
14.3 Ropivacaine Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Ropivacaine Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Ropivacaine Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Ropivacaine Injection Product and Services
Table 6. Pfizer Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Akorn Basic Information, Manufacturing Base and Competitors
Table 9. Akorn Major Business
Table 10. Akorn Ropivacaine Injection Product and Services
Table 11. Akorn Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Akorn Recent Developments/Updates
Table 13. Anant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Anant Pharmaceuticals Major Business
Table 15. Anant Pharmaceuticals Ropivacaine Injection Product and Services
Table 16. Anant Pharmaceuticals Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Anant Pharmaceuticals Recent Developments/Updates
Table 18. SGPharma Basic Information, Manufacturing Base and Competitors
Table 19. SGPharma Major Business
Table 20. SGPharma Ropivacaine Injection Product and Services
Table 21. SGPharma Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. SGPharma Recent Developments/Updates
Table 23. Nephron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Nephron Pharmaceuticals Major Business
Table 25. Nephron Pharmaceuticals Ropivacaine Injection Product and Services
Table 26. Nephron Pharmaceuticals Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nephron Pharmaceuticals Recent Developments/Updates
Table 28. Sintetica SA Basic Information, Manufacturing Base and Competitors
Table 29. Sintetica SA Major Business
Table 30. Sintetica SA Ropivacaine Injection Product and Services
Table 31. Sintetica SA Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sintetica SA Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca Ropivacaine Injection Product and Services
Table 36. AstraZeneca Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 39. Manus Aktteva Biopharma LLP Major Business
Table 40. Manus Aktteva Biopharma LLP Ropivacaine Injection Product and Services
Table 41. Manus Aktteva Biopharma LLP Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 43. Zhejiang Xianju Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
Table 45. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
Table 46. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 48. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
Table 50. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product and Services
Table 51. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 53. Yangzi River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 54. Yangzi River Pharmaceutical Group Major Business
Table 55. Yangzi River Pharmaceutical Group Ropivacaine Injection Product and Services
Table 56. Yangzi River Pharmaceutical Group Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Yangzi River Pharmaceutical Group Recent Developments/Updates
Table 58. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 60. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product and Services
Table 61. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 63. Jiangsu Nhwa Pharmaceutical Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
Table 65. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
Table 66. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates
Table 68. Global Ropivacaine Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Ropivacaine Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Ropivacaine Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Ropivacaine Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Ropivacaine Injection Production Site of Key Manufacturer
Table 73. Ropivacaine Injection Market: Company Product Type Footprint
Table 74. Ropivacaine Injection Market: Company Product Application Footprint
Table 75. Ropivacaine Injection New Market Entrants and Barriers to Market Entry
Table 76. Ropivacaine Injection Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Ropivacaine Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Ropivacaine Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Ropivacaine Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Ropivacaine Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Ropivacaine Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Ropivacaine Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Ropivacaine Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Ropivacaine Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Ropivacaine Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Ropivacaine Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Ropivacaine Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Ropivacaine Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Ropivacaine Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Ropivacaine Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Ropivacaine Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Ropivacaine Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Ropivacaine Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Ropivacaine Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Ropivacaine Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Ropivacaine Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Ropivacaine Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Ropivacaine Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Ropivacaine Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Ropivacaine Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Ropivacaine Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Ropivacaine Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Ropivacaine Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Ropivacaine Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Ropivacaine Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Ropivacaine Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Ropivacaine Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Ropivacaine Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Ropivacaine Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Ropivacaine Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Ropivacaine Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Ropivacaine Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Ropivacaine Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Ropivacaine Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Ropivacaine Injection Raw Material
Table 136. Key Manufacturers of Ropivacaine Injection Raw Materials
Table 137. Ropivacaine Injection Typical Distributors
Table 138. Ropivacaine Injection Typical Customers
List of Figures
Figure 1. Ropivacaine Injection Picture
Figure 2. Global Ropivacaine Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Ropivacaine Injection Consumption Value Market Share by Type in 2022
Figure 4. 2 mg/mL (0.2%) Examples
Figure 5. 5 mg/mL (0.5%) Examples
Figure 6. 7.5 mg/mL (0.75%) Examples
Figure 7. 10 mg/mL (1%) Examples
Figure 8. Global Ropivacaine Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Ropivacaine Injection Consumption Value Market Share by Application in 2022
Figure 10. Surgical Anesthesia Examples
Figure 11. Major Nerve Block Examples
Figure 12. Acute Pain Management Examples
Figure 13. Other Examples
Figure 14. Global Ropivacaine Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Ropivacaine Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Ropivacaine Injection Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Ropivacaine Injection Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Ropivacaine Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Ropivacaine Injection Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Ropivacaine Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Ropivacaine Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Ropivacaine Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Ropivacaine Injection Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Ropivacaine Injection Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Ropivacaine Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Ropivacaine Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Ropivacaine Injection Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Ropivacaine Injection Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Ropivacaine Injection Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Ropivacaine Injection Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Ropivacaine Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Ropivacaine Injection Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Ropivacaine Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Ropivacaine Injection Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Ropivacaine Injection Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Ropivacaine Injection Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Ropivacaine Injection Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Ropivacaine Injection Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Ropivacaine Injection Consumption Value Market Share by Region (2018-2029)
Figure 56. China Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Ropivacaine Injection Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Ropivacaine Injection Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Ropivacaine Injection Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Ropivacaine Injection Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Ropivacaine Injection Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Ropivacaine Injection Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Ropivacaine Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Ropivacaine Injection Market Drivers
Figure 77. Ropivacaine Injection Market Restraints
Figure 78. Ropivacaine Injection Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Ropivacaine Injection in 2022
Figure 81. Manufacturing Process Analysis of Ropivacaine Injection
Figure 82. Ropivacaine Injection Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射用塩酸レミフェンタニル市場2023年：企業・地域・タイプ・用途別分析
  • 世界のプレフィルド注射ペン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の注射用ニコランジル市場2023年：企業・地域・タイプ・用途別分析
  • 世界の小容量インジェクション（SVI）市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデゾシン注射市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM8036 )"世界のロピバカイン注射液市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Ropivacaine Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。